Lunai Bioworks (LNAI) Operating Leases (2019 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Operating Leases of $131316.0 in Q1 2026, down 38.54% quarter-over-quarter from $213657.0 in Q4 2025, and down 73.61% on a YoY basis from $497629.0 in Q1 2025.
Lunai Bioworks (LNAI) Operating Leases (2019 - 2026) Analysis & Trends
Lunai Bioworks' Operating Leases history runs 8 years deep, the most recent figure standing at $131316.0 for Q1 2026.
- In Q1 2026, Operating Leases fell 73.61% year-over-year to $131316.0; the TTM figure through Mar 2026 stood at $131316.0 (down 73.61% YoY), while the FY2025 annual figure was $424547.0, down 49.6% from the prior year.
- Operating Leases was $131316.0 for Q1 2026 at Lunai Bioworks, down from $213657.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $1.0 million in Q1 2022 to a low of $131316.0 in Q1 2026.
- Historically, Operating Leases has averaged $680672.4 across 5 years, with a median of $720801.0 in 2023.
- The sharpest annual moves came in 2024 and 2026: Operating Leases gained 17.02% in 2024, then slumped 73.61% in 2026.
- A 5-year view of Operating Leases shows it stood at $882303.0 in 2022, then fell by 24.72% to $664218.0 in 2023, then advanced by 1.5% to $674200.0 in 2024, then tumbled by 68.31% to $213657.0 in 2025, then sank by 38.54% to $131316.0 in 2026.
- The last three Operating Leases figures came in at $131316.0 (Q1 2026), $213657.0 (Q4 2025), and $278963.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 131,316.00 |
| Dec 31, 2025 | 213,657.00 |
| Sep 30, 2025 | 278,963.00 |
| Jun 30, 2025 | 424,547.00 |
| Mar 31, 2025 | 497,629.00 |
| Dec 31, 2024 | 674,200.00 |
| Sep 30, 2024 | 710,260.00 |
| Jun 30, 2024 | 842,389.00 |
| Mar 31, 2024 | 970,353.00 |
| Dec 31, 2023 | 664,218.00 |
| Sep 30, 2023 | 720,801.00 |
| Jun 30, 2023 | 775,587.00 |
| Mar 31, 2023 | 829,213.00 |
| Dec 31, 2022 | 882,303.00 |
| Sep 30, 2022 | 934,861.00 |
| Jun 30, 2022 | 985,699.00 |
| Mar 31, 2022 | 1.04 Mn |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 1.16 Mn |
| Jun 30, 2021 | 1.24 Mn |